View in EDS HTML Full Text PDF Full Text

SMARCB1 loss activates patient-specific distal oncogenic enhancers in malignant rhabdoid tumors.

Saved in:
Bibliographic Details
Title: SMARCB1 loss activates patient-specific distal oncogenic enhancers in malignant rhabdoid tumors.
Authors: Liu NQ; Division of Gene Regulation, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Hematology, Erasmus Medical Center (MC) Cancer Institute, Rotterdam, the Netherlands., Paassen I; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Custers L; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Zeller P; Oncode Institute, Utrecht, the Netherlands.; Hubrecht Institute-KNAW, Utrecht, the Netherlands.; University Medical Center Utrecht, Utrecht, the Netherlands., Teunissen H; Division of Gene Regulation, Netherlands Cancer Institute, Amsterdam, the Netherlands., Ayyildiz D; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., He J; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Buhl JL; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Hoving EW; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., van Oudenaarden A; Oncode Institute, Utrecht, the Netherlands.; Hubrecht Institute-KNAW, Utrecht, the Netherlands.; University Medical Center Utrecht, Utrecht, the Netherlands., de Wit E; Division of Gene Regulation, Netherlands Cancer Institute, Amsterdam, the Netherlands. e.d.wit@nki.nl., Drost J; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands. J.Drost@prinsesmaximacentrum.nl.; Oncode Institute, Utrecht, the Netherlands. J.Drost@prinsesmaximacentrum.nl.
Source: Nature communications [Nat Commun] 2023 Dec 01; Vol. 14 (1), pp. 7762. Date of Electronic Publication: 2023 Dec 01.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38040699
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: SMARCB1 loss activates patient-specific distal oncogenic enhancers in malignant rhabdoid tumors.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Liu+NQ%22">Liu NQ</searchLink>; Division of Gene Regulation, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Hematology, Erasmus Medical Center (MC) Cancer Institute, Rotterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Paassen+I%22">Paassen I</searchLink>; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Custers+L%22">Custers L</searchLink>; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Zeller+P%22">Zeller P</searchLink>; Oncode Institute, Utrecht, the Netherlands.; Hubrecht Institute-KNAW, Utrecht, the Netherlands.; University Medical Center Utrecht, Utrecht, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Teunissen+H%22">Teunissen H</searchLink>; Division of Gene Regulation, Netherlands Cancer Institute, Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Ayyildiz+D%22">Ayyildiz D</searchLink>; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.<br /><searchLink fieldCode="AU" term="%22He+J%22">He J</searchLink>; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Buhl+JL%22">Buhl JL</searchLink>; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Hoving+EW%22">Hoving EW</searchLink>; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Oudenaarden+A%22">van Oudenaarden A</searchLink>; Oncode Institute, Utrecht, the Netherlands.; Hubrecht Institute-KNAW, Utrecht, the Netherlands.; University Medical Center Utrecht, Utrecht, the Netherlands.<br /><searchLink fieldCode="AU" term="%22de+Wit+E%22">de Wit E</searchLink>; Division of Gene Regulation, Netherlands Cancer Institute, Amsterdam, the Netherlands. e.d.wit@nki.nl.<br /><searchLink fieldCode="AU" term="%22Drost+J%22">Drost J</searchLink>; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands. J.Drost@prinsesmaximacentrum.nl.; Oncode Institute, Utrecht, the Netherlands. J.Drost@prinsesmaximacentrum.nl.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101528555%22">Nature communications</searchLink> [Nat Commun] 2023 Dec 01; Vol. 14 (1), pp. 7762. <i>Date of Electronic Publication: </i>2023 Dec 01.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101528555 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-1723 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220411723%22">20411723 </searchLink><i>NLM ISO Abbreviation: </i>Nat Commun <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38040699
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41467-023-43498-3
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 7762
    Titles:
      – TitleFull: SMARCB1 loss activates patient-specific distal oncogenic enhancers in malignant rhabdoid tumors.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Liu NQ
      – PersonEntity:
          Name:
            NameFull: Paassen I
      – PersonEntity:
          Name:
            NameFull: Custers L
      – PersonEntity:
          Name:
            NameFull: Zeller P
      – PersonEntity:
          Name:
            NameFull: Teunissen H
      – PersonEntity:
          Name:
            NameFull: Ayyildiz D
      – PersonEntity:
          Name:
            NameFull: He J
      – PersonEntity:
          Name:
            NameFull: Buhl JL
      – PersonEntity:
          Name:
            NameFull: Hoving EW
      – PersonEntity:
          Name:
            NameFull: van Oudenaarden A
      – PersonEntity:
          Name:
            NameFull: de Wit E
      – PersonEntity:
          Name:
            NameFull: Drost J
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 12
              Text: 2023 Dec 01
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 2041-1723
          Numbering:
            – Type: volume
              Value: 14
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Nature communications
              Type: main
ResultId 1